Janssen Pharmaceutica launches EU Disease Lens platform

Janssen Health Policy Centre, part of the Belgian drug company Janssen Pharmaceutica,  has launched a “digital dashboard” to accurately inform journalists, policymakers, health-care workers and any interested member of the public about the most common diseases found in Europe.

The goal of the EU Disease Lens is to provide clear and accurate information about disease statistics, history and latest treatments in an age where there is so much online information available, it can be very difficult to make sense of or to corroborate findings and figures.

The site covers 28 diseases, including diabetes, HIV, schizophrenia, depression, Alzheimer’s disease and cancer. The information is gathered from reliable and publicly available sources such as the World Health Organization and the European Commission.

The EU Disease Lens also sheds light on a number of epidemiological statistics, like the percentage of patients of certain diseases in each EU Member States and the average number of years lost due to a certain disease. A quick glance offers such information as “Up to 50% of all people with diabetes are currently unaware of their condition,” and “almost 7% of Europeans over 60 years of age suffer from some form of Alzheimer’s disease”.

Janssen Pharmaceutica, based in Beers, Antwerp province, was founded in 1953 by Belgian pharmacologist Paul Janssen. It has been part of the Johnson & Johnson multinational since 1961.